Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.
Clinical trial NCT03111589 · COMPLETED
Trial details
- NCT number
- NCT03111589
- Sponsor
- Francis Corazza
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-10-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.